Investor Lists

Series C investors in China

Updated 7 November 2026

Firms we have watched take part in a Series C round raised by a company in China in the last two years, wherever the firm is based.

See all 43 →The top 25
43investors on the list+4 this week
454cheques in 12 months+18% against the market
$75Mmedian round they joined+837% against the market median
95%wrote a cheque in 12 months
56%have led a round

The Top 25

Ordered by cheques observed, never by anything anyone paid for

Deploying now (25)

  1. 1Tengxun TouziDeploying nowVC firm · China553$50Mmedian roundNov 2026last seen
  2. 2Qiming Venture PartnersDeploying nowVC firm · Hong Kong SAR China526$25Mmedian roundOct 2026last seen
  3. 3IDG CapitalDeploying nowPrivate equity · China504$25Mmedian roundOct 2026last seen
  4. 4Shenzhen Capital Group Co.Deploying nowGovernment · China449$16Mmedian roundOct 2026last seen
  5. 5OrbiMedDeploying nowPrivate equity · United States447$71Mmedian roundOct 2026last seen
  6. 6Shunwei CapitalDeploying nowVC firm · China288$15Mmedian roundOct 2026last seen
  7. 7Hill House CapitalDeploying nowFamily office · Singapore248$60Mmedian roundSept 2026last seen
  8. 8Gaorong CapitalDeploying nowVC firm · China184$30Mmedian roundNov 2026last seen
  9. 9Alibaba GroupDeploying nowCorporate VC · China113$35Mmedian roundSept 2026last seen
  10. 10Oriza HoldingsDeploying nowVC firm · China101$14Mmedian roundOct 2026last seen
  11. 11AlibabaDeploying nowGrowth equity · United States83$150Mmedian roundOct 2026last seen
  12. 12Kaitai CapitalDeploying nowVC firm · China77$14Mmedian roundOct 2026last seen
  13. 13Ant GroupDeploying nowCorporate VC · China74$25Mmedian roundOct 2026last seen
  14. 14BaiduDeploying nowInvestment firm · China72$36Mmedian roundNov 2026last seen
  15. 15TCG CrossoverDeploying nowVC firm · United States60$150Mmedian roundOct 2026last seen
  16. 16MomentaDeploying nowVC firm · Switzerland46$6.2Mmedian roundSept 2026last seen
  17. 17Sequoia Capital ChinaDeploying nowVC firm · China34$60Mmedian roundOct 2026last seen
  18. 18Decheng CapitalDeploying nowVC firm · United States17$35Mmedian roundSept 2026last seen
  19. 19Mirae AssetDeploying nowVC firm · United States14$53Mmedian roundSept 2026last seen
  20. 20LenovoDeploying nowGrowth equity · China13$41Mmedian roundOct 2026last seen
  21. 21SAICDeploying nowInvestment firm · United States7$80Mmedian roundMay 2026last seen
  22. 22MeituanDeploying nowCorporate VC · China6$150Mmedian roundOct 2026last seen
  23. 23China MobileDeploying nowInvestment firm5$1.6Bmedian roundOct 2026last seen
  24. 24HongShanDeploying nowVC firm5$103Mmedian roundJul 2026last seen
  25. 25Cenova CapitalDeploying nowGrowth equity · China2$75Mmedian roundMay 2026last seen
18 more on this list

All 43 are in the app, with filters for stage, sector and market. A free account shows 10 per search, Pro up to 1,000.

See the whole list →

Reading for founders at Series B and scaling

More books for founders and investors on the Reading List.

As an Amazon Associate we earn from qualifying purchases.

Quick answers about series C investors in China

Who are the most active series C investors in China?

By cheques observed, the most active are Tengxun Touzi, Qiming Venture Partners, IDG Capital, Shenzhen Capital Group Co. and OrbiMed.

How many series C investors in China are there?

43 are on record. 95% made an investment in the last 12 months and 56% have led a round.

Which stages do series C investors in China back?

Of the rounds with a named stage in the last 12 months, mostly Series A (22%) and Series B (22%).

How big are the rounds series C investors in China join?

The typical (median) round among the leading investors here is $41M.

Which sectors do series C investors in China back most?

In the last 12 months, mostly AI, Biotech and Healthcare.

Which series C investors in China lead the most rounds?

Tengxun Touzi (20 led), OrbiMed (9 led) and Qiming Venture Partners (8 led).

Where are series C investors in China based?

Among the most active, most are based in China (14), the United States (6) and Hong Kong SAR China (1).

What have series C investors in China invested in recently?

Recent rounds include T-Therapeutics (Series B, Nov 2026, with Tengxun Touzi), Nanochap (Series C, Nov 2026, with Gaorong Capital) and GenRobot AI (Series A, Nov 2026, with Baidu).

Built from the rounds we watched, refreshed every night. How we count · Report a correction